{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:26:15Z","timestamp":1789475175403,"version":"build-2803163510"},"reference-count":51,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2016.00047","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T03:05:47Z","timestamp":1463108747000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":121,"title":["Hemophagocytic Lymphohistiocytosis in Children: Pathogenesis and Treatment"],"prefix":"10.3389","volume":"4","author":[{"given":"Eiichi","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1096-911X(199805)30:5276::AID-MPO33.0.CO;2-C","article-title":"Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan","volume":"30","author":"Ishii","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2004.11.002","article-title":"Review of familial hemophagocytic lymphohistiocytosis (FHL) in children with focus on Japanese experiences","volume":"53","author":"Ishii","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e14173","DOI":"10.1371\/journal.pone.0014173","article-title":"Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes","volume":"5","author":"Nagai","year":"2010","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B10","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","article-title":"Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment","volume":"66","author":"Imashuku","year":"1997","journal-title":"Int J Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"Kagi","year":"1994","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.4049\/jimmunol.170.4.2205","article-title":"Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells","volume":"170","author":"Yanai","year":"2003","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","article-title":"Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte\/natural killer cell functions","volume":"105","author":"Ishii","year":"2005","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.0105-2896.2005.00224.x","article-title":"Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis","volume":"203","author":"Menasche","year":"2005","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/35052017","article-title":"SNARE-mediated membrane fusion","volume":"2","author":"Chen","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tcb.2005.10.003","article-title":"Cytotoxic T lymphocyte exocytosis: bring on the SNAREs","volume":"15","author":"Hong","year":"2005","journal-title":"Trends Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1086\/302187","article-title":"Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping","volume":"64","author":"Ohadi","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"C\u00f4te","year":"2009","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3324\/haematol.2009.016949","article-title":"UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis","volume":"95","author":"Yoon","year":"2010","journal-title":"Haematologica"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.cellbio.23.090506.123521","article-title":"Secretory mechanisms in cell-mediated cytotoxicity","volume":"23","author":"Stinchcombe","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/j.1600-0854.2008.00759.x","article-title":"Vesicle docking in regulated exocytosis","volume":"9","author":"Verhage","year":"2008","journal-title":"Traffic"},{"key":"B27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1126\/science.1161748","article-title":"Membrane fusion: grappling with SNARE and SM proteins","volume":"323","author":"Sudhof","year":"2009","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ajh.20878","article-title":"Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations","volume":"82","author":"Ueda","year":"2007","journal-title":"Am J Hematol"},{"key":"B29","first-page":"620","article-title":"Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42-q44 in a segment of conserved synteny that includes the mouse beige locus (bg)","volume":"59","author":"Fukai","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03402003","article-title":"The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins","volume":"8","author":"Tchernev","year":"2002","journal-title":"Mol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1182\/blood-2011-05-356113","article-title":"Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Ch\u00e9diak-Higashi syndrome","volume":"118","author":"Jessen","year":"2011","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/pbc.24637","article-title":"Clinical characteristics and outcomes of Ch\u00e9diak-Higashi syndrome: a nationwide survey of Japan","volume":"10","author":"Nagai","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI116721","article-title":"Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome","volume":"92","author":"Kawaguchi","year":"1993","journal-title":"J Clin Invest"},{"key":"B34","first-page":"97","article-title":"Immune surveillance against Epstein-Barr virus","volume":"4","author":"Moss","year":"1992","journal-title":"Semin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","article-title":"Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"44","author":"Kasahara","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1525-1578(10)60580-6","article-title":"BIOMED-2 multiplex immunoglobulin\/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics","volume":"7","author":"Sandberg","year":"2005","journal-title":"J Mol Diagn"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.cca.2011.04.036","article-title":"Detection of T-cell receptor gene rearrangement in children with Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis","volume":"412","author":"Matsuda","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jpeds.2009.02.050","article-title":"Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan","volume":"155","author":"Suzuki","year":"2009","journal-title":"J Pediatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00001432-200406000-00012","article-title":"Neonatal herpes simplex virus infection","volume":"17","author":"Whitley","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/01.inf.0000164810.60080.ad","article-title":"Diagnosis and outcomes of enterovirus infections in young infants","volume":"24","author":"Rittichier","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphihistiocytosis (HLH) and related disorders","volume":"2009","author":"Filipovich","year":"2009","journal-title":"Hematology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan histiocytosis study group","volume":"61","author":"Kogawa","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pbc.22310","article-title":"Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan","volume":"54","author":"Ohga","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ajh.23190","article-title":"Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis","volume":"87","author":"Nishi","year":"2012","journal-title":"Am J Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","article-title":"Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"29","author":"Balamuth","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T19:43:45Z","timestamp":1600544625000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fped.2016.00047\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,13]]},"references-count":51,"URL":"https:\/\/doi.org\/10.3389\/fped.2016.00047","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,13]]}}}